A reversible defect of platelet PDGF content in myeloproliferative disorders
- 1 August 1988
- journal article
- Published by Wiley in British Journal of Haematology
- Vol. 69 (4) , 483-486
- https://doi.org/10.1111/j.1365-2141.1988.00477.x-i1
Abstract
No abstract availableKeywords
This publication has 16 references indexed in Scilit:
- 125I fibrinogen turnover in polycythaemia: the effect of phlebotomyBritish Journal of Haematology, 2008
- Composition of immune complexes and their relation to plasma fibronectin in chronic myeloproliferative disorders.Journal of Clinical Pathology, 1987
- Platelet‐derived growth factor(s) mitogenic activity in patients with myeloproliferative diseaseBritish Journal of Haematology, 1986
- Platelet factor‐4 excretion in myeloproliferative disease: implications for the aetiology of myelofibrosisBritish Journal of Haematology, 1984
- Inhibition of platelet aggregation by fibronectinBiochemical and Biophysical Research Communications, 1983
- The Pathogenesis of Myelofibrosis in Myeloproliferative DisordersAnnals of Internal Medicine, 1980
- Chronic Myeloproliferative Disorders: A Quantitative Assessment of Platelet UltrastructureActa Haematologica, 1980
- Platelet and Plasma β Thromboglobulin in Mycloproliferative Syndromes and Secondary ThrombocytosisBritish Journal of Haematology, 1978
- Immune Complexes in Myelofibrosis: a Possible Guide to ManagementBritish Journal of Haematology, 1978
- Metabolism of Human Prothrombin and Fibrinogen in Patients With Thrombocytosis Secondary to Myeloproliferative StatesBlood, 1973